Loyda E. Braithwaite, NP, University of Wisconsin Carbone Cancer Center
Advertisement
Articles by Loyda E. Braithwaite, NP, University of Wisconsin Carbone Cancer Center
Advertisement
Latest Updated Articles
Management of Adverse Effects in R/R HER2+ mBCPublished: September 23rd 2020 | Updated:
FDA-approved Therapies for Relapsed/Refractory HER2+ mBCPublished: September 23rd 2020 | Updated:
Practical Management of Early Stage HER2+ Breast CancerPublished: September 23rd 2020 | Updated:
HER2-targeted Therapy: Routes of AdministrationPublished: September 23rd 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Accepts BLA for Ivonescimab Plus Chemotherapy in EGFR-Mutant NSCLC After TKI Progression
2
The OncFive: Top Oncology Articles for the Week of 1/25
3
HPV Vaccination and Evolving Screening Strategies Continue to Shape Cervical Cancer Prevention Efforts
4
FDA Approval Sought for Lirafugratinib in Second-Line, FGFR2-Altered Cholangiocarcinoma
5